PLAU, plasminogen activator, urokinase, 5328

N. diseases: 439; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 Biomarker group CTD_human Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors. 16430655 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 Biomarker group LHGDN RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo. 16127174 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 AlteredExpression group LHGDN Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. 15886816 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 AlteredExpression group LHGDN Clinical significance of expression of urokinase-type plasminogen activator in patients with prostate cancer. 12926141 2003
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 Biomarker group CTD_human Is urokinase gene 3'-UTR polymorphism associated with prostate cancer? 17192053 2005
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 Biomarker group CTD_human Amplification of urokinase gene in prostate cancer. 11454671 2001
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 AlteredExpression group LHGDN Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer. 16949925 2006
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 PosttranslationalModification group LHGDN Methylation status of uPA promoter as a molecular mechanism regulating prostate cancer invasion and growth in vitro and in vivo. 12773490 2003
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.360 GeneticVariation group LHGDN Is urokinase gene 3'-UTR polymorphism associated with prostate cancer? 17192053 2005